| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.85 (Miss by $-0.11) |
| EPS GAAP Actual | $0.85 (Miss by $-0.11) |
| Revenue Actual | $0.39761B |
| Revenue Surprise | Beat by $397.61M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.72565 |
| EPS GAAP Estimate | $0.72565 |
| Revenue Estimate | $0.376142B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.85 | 0.10925 | 0.39761B | 15.88% | 15.54M |
| FQ2 2025 (Jun 2025) | 0.55 | -0.18899 | 0.339527B | -12.1% | -38.45M |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 0.340252B | 2.84% | 340.25M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.389615B | 365.14% | 389.62M |
| FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 0.334484B | 3.97% | 334.48M |
| FQ2 2024 (Jun 2024) | 0.77 | 0.77 | 0.380626B | 16.13% | 380.63M |
| FQ1 2024 (Mar 2024) | 0.64 | 0.64 | 0.330582B | -7.45% | 330.58M |
| FQ4 2023 (Dec 2023) | 0.8 | 0.8 | -1.03301B | 132.56% | -1033.01M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.72565
Consensus Revenue Estimates
0.376142B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.80613 | -- | 0.77656 | 0.82122 | 1 |
| FQ3 2027 (Sep 2027) | 0.81198 | -- | 0.78006 | 0.83361 | 1 |
| FQ2 2027 (Jun 2027) | 0.8023 | -- | 0.77076 | 0.82367 | 1 |
| FQ1 2027 (Mar 2027) | 0.79516 | -- | 0.7639 | 0.81634 | 1 |
| FQ4 2026 (Oct 2026) | 0.74369 | -- | 0.68403 | 0.76081 | 3 |
| FQ3 2026 (Jul 2026) | 0.73676 | -15.37 | 0.67766 | 0.75372 | 5 |
| FQ2 2026 (Jun 2026) | 0.72682 | 24.33 | 0.65852 | 0.74759 | 5 |
| FQ1 2026 (Mar 2026) | 0.72565 | 17.32 | 0.65746 | 0.74638 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.45B | -- | 0.44B | 0.46B | 5 |
| FQ3 2027 (Sep 2027) | 0.44B | -- | 0.42B | 0.45B | 3 |
| FQ2 2027 (Jun 2027) | 0.43B | -- | 0.42B | 0.44B | 3 |
| FQ1 2027 (Mar 2027) | 0.43B | -- | 0.42B | 0.44B | 3 |
| FQ4 2026 (Oct 2026) | 0.39B | -- | 0.37B | 0.4B | 8 |
| FQ3 2026 (Jul 2026) | 0.39B | -2.74 | 0.36B | 0.39B | 5 |
| FQ2 2026 (Jun 2026) | 0.38B | 9.85 | 0.35B | 0.38B | 5 |
| FQ1 2026 (Mar 2026) | 0.38B | 9.54 | 0.35B | 0.38B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.74075 | 0.85 | 0.10925 | 12.85% |
| FQ2 2025 (Jun 2025) | 0.73899 | 0.55 | -0.18899 | -34.36% |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 100% | |
| FQ2 2024 (Jun 2024) | 0.77 | 0.77 | 100% | |
| FQ1 2024 (Mar 2024) | 0.64 | 0.64 | 100% | |
| FQ4 2023 (Dec 2023) | 0.8 | 0.8 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.38B | $0.4B | $15.54M | 3.91% |
| FQ2 2025 (Jun 2025) | $0.38B | $0.34B | $-38.45M | -11.32% |
| FQ1 2025 (Mar 2025) | $0B | $0.34B | $340.25M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.39B | $389.62M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.33B | $334.48M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.38B | $380.63M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.33B | $330.58M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $-1.03B | $-1033.01M | 100% |